98%
921
2 minutes
20
Background: The safety of internal thoracic artery (ITA) grafting in patients undergoing coronary artery bypass grafting (CABG) with prior mediastinal radiation remains controversial due to concerns regarding compromised sternal perfusion and radiation-induced injury. This study evaluated whether prior mediastinal radiation is associated with adverse perioperative outcomes in patients undergoing CABG with ITA grafting.
Methods: We conducted a retrospective cohort study using the Maryland Cardiac Surgery Quality Initiative (MCSQI) database. A total of 29 206 patients who underwent CABG with ITA use between 1 July 2011 and 31 March 2023 were analysed. Patients with and without prior mediastinal radiation were propensity-matched (1:10) using the nearest neighbour method. The primary outcome was the composite of operative mortality and deep sternal wound infection (DSWI). Secondary outcomes included other infectious complications, major morbidities, postoperative hospital length of stay, and 30-day readmission.
Results: Among 29 206 patients, 294 (1%) had a history of mediastinal radiation. Patients with prior radiation were older (median (IQR) 70 (60-75) vs 66 (59-73) years, p<0.001), more frequently female (66% vs 25%, p<0.001) and had a higher prevalence of chronic lung disease (31% vs 19%, p<0.001). After propensity matching, no significant differences were observed in the primary composite outcome (2% vs 3%, p=0.53) or in secondary outcomes.
Conclusions: In this large retrospective cohort, prior mediastinal radiation was not associated with an increased risk of perioperative adverse events in patients undergoing CABG receiving ITA grafts. These findings demonstrate no evidence of safety concerns with the use of ITA grafting in patients with prior radiation and challenge the practice of excluding these patients from arterial revascularisation strategies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1136/heartjnl-2025-325949 | DOI Listing |
Front Oncol
August 2025
Radiation Oncology, Southeast Health, Dothan, AL, United States.
Perivascular epithelioid cell tumors (PEComas) are rare, typically benign soft tissue tumors that can develop at various anatomic sites. Malignant PEComas are rarer entities but may present aggressively with metastasis to the lungs or local recurrence years after initial presentation. In unresectable or metastatic cases, treatment options are limited due to the resistance of PEComas to chemotherapy and radiotherapy.
View Article and Find Full Text PDFFront Oncol
August 2025
Department of Internal Medicine and Medical Therapeutics, University of Pavia Medical School, Pavia, Italy.
Background: Radiation therapy is used in the clinical scenario of oligo-metastatic lung cancer as a weapon to delay the subsequent line of systemic therapy, particularly in the case of oligo-progressive disease. In this setting, the integration of immunotherapy and radiotherapy plays an important role to achieve local control and improve progression-free survival (PFS).
Case Presentation: We reported the case of an elderly fragile patient affected by advanced non-small cell lung cancer treated with pembrolizumab as first systemic line and immuno-modulant radiation therapy at oligo-progression.
JACC Case Rep
August 2025
Manchester Heart Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Background: High-dose mediastinal radiotherapy can result in progressive valvular degeneration and secondary malignancy.
Case Summary: A 50-year-old woman with prior chest radiotherapy and stem cell transplantation for Hodgkin lymphoma presented with progressive exertional dyspnea. Transthoracic and transesophageal echocardiography revealed severe mitral regurgitation with mitral annular calcification and an incidental finding of a mobile 12 × 8 mm left atrial mass.
Cureus
July 2025
Internal Medicine, O'Connor Hospital, San Jose, USA.
Merkel cell carcinoma (MCC) is a highly aggressive neuroendocrine tumor, known for its rapid progression and poor prognosis. It most commonly affects elderly and immunocompromised individuals, with variable clinical presentations that can make diagnosis challenging. MCC is often mistaken for other skin malignancies, such as basal or squamous cell carcinoma, or even benign skin lesions.
View Article and Find Full Text PDFIndian J Thorac Cardiovasc Surg
September 2025
Department of Thoracic Oncosurgery, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, 110085 India.
Unlabelled: With advances in systemic anticancer therapies, pulmonary metastasectomy is being increasingly employed for local disease control while aiming to preserve lung parenchyma, anatomy, and function with complete (R0) resection. We introduce an innovative neodymium-doped yttrium aluminum garnet (Nd-YAG) light amplification by stimulated emission of radiation (LASER) approach for peripherally located, deep-seated, and fissural lesions, utilizing the lung's natural tongue-like configuration at the edges. This method involves cylindrical excision around the nodule, creating a buttonhole from one surface to the other.
View Article and Find Full Text PDF